Sign In
Buy TTI
$7.70
+0.0800 (+1.05%)
At Close: Jul 31, 2026
3 Reasons Why Growth Investors Shouldn't Overlook Tetra Technologies (TTI)
01:46pm, Tuesday, 30'th Sep 2025
Tetra Technologies (TTI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are You Looking for a Top Momentum Pick? Why Tetra Technologies (TTI) is a Great Choice
01:01pm, Tuesday, 30'th Sep 2025
Does Tetra Technologies (TTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
TETRA Technologies, Inc. (TTI) Analyst/Investor Day Transcript
05:17pm, Thursday, 25'th Sep 2025
TETRA Technologies, Inc. (NYSE:TTI ) Analyst/Investor Day September 25, 2025 8:30 AM EDT Company Participants Kurt Hallead - Treasurer & VP of Investor Relations Brady Murphy - President, CEO & Direct
TETRA TECHNOLOGIES, INC. OUTLINES ONE TETRA 2030 GROWTH STRATEGY FOR ENHANCED SHAREHOLDER VALUE AT NYSE INVESTOR DAY
12:00pm, Thursday, 25'th Sep 2025
Outlines road map to double revenues and more than triple adjusted EBITDA and increase free cash flow by the end of the decade through expansion into the water desalination and energy storage sectors.
TETRA TECHNOLOGIES, INC. ANNOUNCES RESOURCE UPGRADE FOR ARKANSAS BROMINE PROJECT AND ADDITIONAL CRITICAL MINERALS
08:00am, Tuesday, 23'rd Sep 2025
Investor Day Scheduled for September 25 at the New York Stock Exchange THE WOODLANDS, Texas , Sept. 23, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced to
TETRA TECHNOLOGIES, INC. INVESTOR DAY SCHEDULED ON SEPTEMBER 25, 2025, AT THE NEW YORK STOCK EXCHANGE
03:52pm, Wednesday, 17'th Sep 2025
THE WOODLANDS, Texas , Sept. 17, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) will be hosting an Investor Day on Thursday, September 25, 2025, at 8:30AM EST, at
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN THE H.C.
01:26pm, Monday, 08'th Sep 2025
THE WOODLANDS, Texas , Sept. 8, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) will be participating at the 27th Annual H.C.
Top 2 Energy Stocks That May Fall Off A Cliff This Quarter
08:48am, Friday, 01'st Aug 2025
As of Aug. 1, 2025, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
TETRA Technologies, Inc. (TTI) Q2 2025 Earnings Call Transcript
01:03pm, Wednesday, 30'th Jul 2025
TETRA Technologies, Inc. (NYSE:TTI ) Q2 2025 Earnings Conference Call July 30, 2025 10:30 AM ET Company Participants Brady M. Murphy - President, CEO & Director Elijio V.
Tetra Technologies (TTI) Q2 Earnings Match Estimates
07:11pm, Tuesday, 29'th Jul 2025
Tetra Technologies (TTI) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.07 per share a year ago.
TETRA TECHNOLOGIES, INC. ANNOUNCES STRONG SECOND QUARTER 2025 RESULTS AND PROVIDES FULL YEAR GUIDANCE
05:00pm, Tuesday, 29'th Jul 2025
Second Quarter 2025 Financial Highlights Revenue of $174 million increased 11% sequentially Net income before taxes of $19.4 million increased $14.4 million sequentially Adjusted EBITDA of $35.9 milli
TETRA TECHNOLOGIES, INC. ANNOUNCES SECOND QUARTER 2025 EARNINGS RELEASE CONFERENCE CALL AND WEBCAST
09:00am, Tuesday, 08'th Jul 2025
THE WOODLANDS, Texas , July 8, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced today that it will release second quarter 2025 results after the closing of
Thiogenesis Receives Confirmatory Guidance on IMPD for Pediatric MASH Phase 2a Clinical Trial in Europe and Core Patent Granted in EU
09:00am, Wednesday, 25'th Jun 2025
San Diego, California--(Newsfile Corp. - June 25, 2025) - Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based t
Thiogenesis Therapeutics to Present at UMDF's Mitochondrial Medicine 2025 Conference
09:00am, Friday, 20'th Jun 2025
Dr. Rioux to Highlight Industry-Leading Clinical Programs in MELAS and Leigh Syndrome Spectrum San Diego, California--(Newsfile Corp. - June 20, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OT
Thiogenesis Announces Second Site Begins Enrolling in Phase 2 MELAS Clinical Trial and Provides Update
09:00am, Tuesday, 17'th Jun 2025
San Diego, California--(Newsfile Corp. - June 17, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biopharmaceutical company develop
